CAS: 138182-21-5; (2S,3R,4S,5R,6R)-2-((6-Chloro-1H-Indol-3-yl)Oxy)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-3,4,5-Triol
该化合物是一种多用途合成化合物,广泛用于生化研究,该化合物具有氯化蛋白类和β-D-galactopyranoside modie,具有高度选择性和特殊性.其结构特征使其能够成为研究细胞信号和酶动能的有力工具.该化合物以其在不同溶剂中的溶解性而闻名,便于其在各种生化实验中使用.
- 英文名称(2S,3R,4S,5R,6R)-2-((6-Chloro-1H-Indol-3-yl)Oxy)-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-3,4,5-Triol
- 中文名称6-氯-3-吲哚基-D-吡喃半乳糖苷
- IUPAC名称(2S,3R,4S,5R,6R)-2-((6-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- 其它别名6-Chloro-3-Indolyl- Beta -D-Galactopyranoside; Beta-D-Galactopyranoside, 6-Chloro-1H-Indol-3-Yl; 6-Chloro-3-Indoxyl-Beta-D-Galactopyranoside; 6-Chloro-3-Indolyl-Beta-D-Galactopyranoside; (2S,3R,4S
- CAS编号138182-21-5
- MFCD编号:MFCD00467206
- EINECS号:604-065-1
- 分子式:C14H16ClNO6分子量:329.74
- 产品CID: 594496
- 产品分类生物化工 → 糖类化合物 → 单糖
物理性质
- 熔点188-190°C
- 沸点630.2±55.0 °C at 760 mmHg
- 闪点335.0±31.5 °C
- 密度1.6±0.1 g/cm3
- pKa:12.84±0.70(预测)
- PSA:115.17
- LogP:-0.15
- 折射率1.717
- 蒸汽压0.0±1.9 mmHg at 25°C
- 溶解性Insoluble In Water. Soluble In DMSO And DMFo, Methanol.
- 敏感性易受潮
- 外观形态白色至淡黄色粉末
- 储存条件-20°C
- 产品应用该化合物用于减少毒性的药物中间体和诊断试剂中的酶基质; 与IPTG一起使用沙门藻,用共光测定检测检测法检测细菌群中的Β-甘代谢活动,以检测非共生剂(SALMON)的重组剂(白色); 与X-GLU一起,鲑鱼藻有助于同时检测同一板上的GUS和LAC活动.
- 性质描述6-氯-3-吲哚基-β-D-吡喃半乳糖苷(138182-21-5)的性状:该产品的外观呈亮棕色粉末.
MSDS等安全信息
欧盟法规
C&L通报REACH预注册合成工艺路线路线简述
海关参考信息
- 2903919090-氯苯
2905122000-异丙醇
2905310000-1,2-乙二醇
2905320000-1,2-丙二醇 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-6420110-B1
优先权日:1998-10-19
标 题 :Methods and reagents for isolating biologically active peptides
发明人：GYURIS JENO; MORRIS AARON J
权利人:GPC BIOTECH INC
摘要:One aspect of the present invention is the synthesis of a binary method that combines variegated peptide display libraries, e.g., in a “display modeâ€?, with soluble secreted peptide libraries, e.g., in a “secretion modeâ€?, to yield a method for the efficient isolation of peptides having a desired biological activity.
专利号:US-2002025536-A1
优先权日:2000-06-26
标 题:Methods and reagents for isolating biologically active antibodies
发明人：GYURIS JENO; EWERT SEBASTIAN-MEIER; NAGY ZOLTON; MORRIS AARON
摘要:One aspect of the present invention is the synthesis of a binary method that combines variegated antibody display libraries, e.g., in a “display modeâ€?, with soluble secreted antibody libraries, e.g., in a “secretion modeâ€?, to yield a method for the efficient isolation of antibodies having a desired biological activity.
